The dismissal of antitrust claims is a setback but not fatal; the patent infringement case continues. Treace may amend its antitrust claims, but the court's skepticism on antitrust injury is a headwind. Monitor for any amended complaint or developments in the patent case.
Price Chart
Executive Summary
The District of New Jersey granted Stryker's motion to dismiss Treace's antitrust (Sherman Act, Clayton Act, state antitrust) and tortious interference claims without prejudice, finding Treace failed to plead antitrust injury. The patent infringement claims (Counts I-XII) survive. The ruling removes a potential avenue for broad relief but does not end the litigation.
Court Ruling Details
Key Facts
- Court granted motion to dismiss Counts XIII–XVI (antitrust and tortious interference) without prejudice.
- Treace failed to plead antitrust injury — allegations were conclusory and only alleged harm to itself, not to competition in the TMT Bunion Systems Market.
- Patent infringement claims (Counts I–XII) remain pending.
- Treace may file a second amended complaint to attempt to cure the pleading deficiencies.
Financial Impact
No monetary relief ordered; dismissal without prejudice preserves ability to replead. Patent case continues with no immediate financial impact.
Risk Factors
- Treace may fail to adequately replead antitrust injury, leading to dismissal with prejudice.
- Patent case carries its own risks — Stryker may seek invalidity or non-infringement rulings.
- Litigation costs and management distraction could pressure the small-cap stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-889e1f0a26-TMCI |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 7, 2026 8w ago | 8-K | $4.76 $4.81 | ▲ +1.05% | ▲ +1.45% | $4.39 (−7.77%) |
Jul 13, 2026 11w ago | Court Ruling | $4.58 $4.67 | ▼ −1.97% | ▲ +1.22% | $4.39 (+4.15%) |
May 8, 2026 21w ago | Press Release | $2.01 $3.51 | ▼ −74.63% | ▼ −74.60% | $4.39 (−118.41%) |
Apr 24, 2026 23w ago | Press Release | $1.98 $2.84 | ▲ +43.43% | ▲ +39.41% | $4.39 (+121.72%) |
Apr 9, 2026 25w ago | 8-K | $1.53 $1.93 | ▲ +26.14% | ▲ +18.58% | $4.39 (+186.93%) |
Apr 6, 2026 25w ago | DEFA14A | $1.44 $1.83 | ▲ +27.08% | ▲ +18.10% | $4.39 (+204.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access